FDA.reportPublic FDA data

Docusate Sodium 50 mg and Sennosides 8.6 mg Tablets

Manufacturer
Morepen Laboratories Limited
Effective date
2026-01-23
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:34:34

Label at a glance#

ProductDocusate Sodium and Sennosides
Active ingredientDOCUSATE SODIUM, SENNOSIDES
Label structure13 sections

Label contents#

Full prescribing information#

Active Ingredients Label

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient LabelActive Ingredient Label

Inactive Ingredients Section Label

INACTIVE INGREDIENT SECTION

Inactive Ingredients LabelInactive Ingredients Label

Purpose Section Label

OTC - PURPOSE SECTION

Purpose LabelPurpose Label

Indications & Usage Seciton Label

INDICATIONS & USAGE SECTION

Indications & UsageIndications & Usage

Dosage & Administration Section Label

DOSAGE & ADMINISTRATION SECTION

Dosage & AdministrationDosage & Administration

Questions Section Label

OTC - QUESTIONS SECTION

Questions & CommentsQuestions & Comments

Warnings Section Label

WARNINGS SECTION

WarningsWarnings

Keep out or Reach of Children Label

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of Reach of ChildrenKeep out of Reach of Children

Storage and Handling Section Label

STORAGE AND HANDLING SECTION

Storage and HandlingStorage and Handling

30 Tablets Bottle Label (NDC 62993-0002-1)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Primary Display Panel 30 TabletsPrimary Display Panel 30 Tablets

60 Tablets Bottle Label (NDC 62993-0002-2)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Primary Display Panel 60 TabletsPrimary Display Panel 60 Tablets

100 Tablets Bottle Label (NDC 62993-0002-3)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Primary Display Panel 100 TabletsPrimary Display Panel 100 Tablets

1000 Tablets Bottle Label (NDC 62993-0002-4)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Primary Display Panel 1000 TabletsPrimary Display Panel 1000 Tablets

3000 Tablets Bottle Label (NDC 62993-0002-5)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Primary Display Panel 3000 TabletsPrimary Display Panel 3000 Tablets

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
998740sennosides 8.6 MG / docusate sodium 50 MG Oral TabletPSN2
998740docusate sodium 50 MG / sennosides, USP 8.6 MG Oral TabletSCD2
998740DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral TabletSY2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62993-0002-1Docusate Sodium and Sennosides30 in 1 BOTTLETABLET302
62993-0002-2Docusate Sodium and Sennosides60 in 1 BOTTLETABLET602
62993-0002-3Docusate Sodium and Sennosides100 in 1 BOTTLETABLET1002
62993-0002-4Docusate Sodium and Sennosides1000 in 1 BOTTLETABLET10002
62993-0002-5Docusate Sodium and Sennosides3000 in 1 BOTTLETABLET30002

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62993-0002-1EA - Each62993-00028de5b6e7-78c1-4e96-a2e3-a59c7a54735212026-05-22
62993-0002-2EA - Each62993-000234e7f982-0b62-47b0-b752-24bf6a12ee2a12026-05-22
62993-0002-3EA - Each62993-00024c536160-78d8-4adc-af74-9fdded62b06512026-05-22

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62993-000262993-0002-1, 62993-0002-2, 62993-0002-3, 62993-0002-4, 62993-0002-5

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Name, UNII, Kind table
NameUNIIKind
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSL11K75P92JIACT
TALC7SEV7J4R1UIACT
POVIDONE K30U725QWY32XIACT
POLYETHYLENE GLYCOL, UNSPECIFIED3WJQ0SDW1AIACT
SILICON DIOXIDEETJ7Z6XBU4IACT
HYPROMELLOSE, UNSPECIFIED3NXW29V3WOIACT
TITANIUM DIOXIDE15FIX9V2JPIACT
DOCUSATE SODIUMF05Q2T2JA0ACTIB
SENNOSIDES3FYP5M0IJXACTIB
CROSCARMELLOSE SODIUMM28OL1HH48IACT
FD&C YELLOW NO. 6H77VEI93A8IACT
MAGNESIUM STEARATE70097M6I30IACT
MICROCRYSTALLINE CELLULOSEOP1R32D61UIACT
FD&C YELLOW NO. 5I753WB2F1MIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Docusate Sodium and SennosidesDOCUSATE SODIUM AND SENNOSIDESMorepen Laboratories Limited3cf42333-7479-940a-e063-6394a90aedee2026-01-23WarningsExact identifier
ndc (package): 62993-0002-3
ndc (package): 62993-0002-4
ndc (package): 62993-0002-5
ndc (package): 62993-0002-1
ndc (package): 62993-0002-2
ndc (product): 62993-0002
ndc11 (package): 62993000201
ndc11 (package): 62993000204
ndc11 (package): 62993000202
ndc11 (package): 62993000203
ndc11 (package): 62993000205
spl id: 48f5ab82-91b0-71fa-e063-6294a90a74c9
spl set id: 3cf42333-7479-940a-e063-6394a90aedee

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.